rs2246833

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000235.4(LIPA):​c.112-304G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.379 in 151,904 control chromosomes in the GnomAD database, including 11,201 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.38 ( 11201 hom., cov: 32)

Consequence

LIPA
NM_000235.4 intron

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.200

Publications

61 publications found
Variant links:
Genes affected
LIPA (HGNC:6617): (lipase A, lysosomal acid type) This gene encodes lipase A, the lysosomal acid lipase (also known as cholesterol ester hydrolase). This enzyme functions in the lysosome to catalyze the hydrolysis of cholesteryl esters and triglycerides. Mutations in this gene can result in Wolman disease and cholesteryl ester storage disease. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2014]
LIPA Gene-Disease associations (from GenCC):
  • lysosomal acid lipase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • lysosomal acid lipase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women's Health, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • cholesteryl ester storage disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Wolman disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000235.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 10-89246097-C-T is Benign according to our data. Variant chr10-89246097-C-T is described in ClinVar as Benign. ClinVar VariationId is 684269.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.509 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000235.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LIPA
NM_000235.4
MANE Select
c.112-304G>A
intron
N/ANP_000226.2P38571-1
LIPA
NM_001440836.1
c.244-304G>A
intron
N/ANP_001427765.1
LIPA
NM_001440837.1
c.112-304G>A
intron
N/ANP_001427766.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LIPA
ENST00000336233.10
TSL:1 MANE Select
c.112-304G>A
intron
N/AENSP00000337354.5P38571-1
LIPA
ENST00000428800.5
TSL:1
c.112-304G>A
intron
N/AENSP00000388415.1Q5T073
LIPA
ENST00000868683.1
c.112-304G>A
intron
N/AENSP00000538742.1

Frequencies

GnomAD3 genomes
AF:
0.378
AC:
57444
AN:
151784
Hom.:
11173
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.410
Gnomad AMI
AF:
0.160
Gnomad AMR
AF:
0.428
Gnomad ASJ
AF:
0.361
Gnomad EAS
AF:
0.338
Gnomad SAS
AF:
0.527
Gnomad FIN
AF:
0.406
Gnomad MID
AF:
0.427
Gnomad NFE
AF:
0.340
Gnomad OTH
AF:
0.372
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.379
AC:
57516
AN:
151904
Hom.:
11201
Cov.:
32
AF XY:
0.382
AC XY:
28312
AN XY:
74210
show subpopulations
African (AFR)
AF:
0.411
AC:
16998
AN:
41402
American (AMR)
AF:
0.430
AC:
6552
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.361
AC:
1252
AN:
3464
East Asian (EAS)
AF:
0.337
AC:
1743
AN:
5170
South Asian (SAS)
AF:
0.526
AC:
2533
AN:
4818
European-Finnish (FIN)
AF:
0.406
AC:
4270
AN:
10528
Middle Eastern (MID)
AF:
0.435
AC:
127
AN:
292
European-Non Finnish (NFE)
AF:
0.340
AC:
23113
AN:
67958
Other (OTH)
AF:
0.371
AC:
782
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1812
3625
5437
7250
9062
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
574
1148
1722
2296
2870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.366
Hom.:
8793
Bravo
AF:
0.380
Asia WGS
AF:
0.479
AC:
1668
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Wolman disease (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
3.1
DANN
Benign
0.39
PhyloP100
-0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2246833;
hg19: chr10-91005854;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.